Antifungal Drugs Market Insight on the Important Factors and Trends Influencing

1. Antifungal Drugs Market Global Analysis and Forecast to 2027 Published Date : Jul 2019 Email: sales@theinsightpartners.com

2. Email: sales@theinsightpartners.com Report Studies  Antifungal Drugs Market to 2027 - Global Analysis and Forecasts By Infection Type (Superficial Fungal Infection, Systemic Fungal Infection); Drug Type (Echinocandins, Azoles, Polyenes, Allylamines, Others); Therapeutic Indication (Aspergillosis, Dermatophytosis, Candidiasis, Others); Dosage form (Drugs, Ointment, Powder, Others), and Geography  The Antifungal Drugs market accounted to US$ 10,182.3 Mn in 2018 and is expected to grow at a CAGR of 3.2% during the forecast period 2019 – 2027, to account to US$ 13,524.2 Mn by 2027. 2

3. Email: sales@theinsightpartners.com Antifungal Drugs Market Overview  Global Antifungal Drugs market was segmented by infection type, drug type, therapeutic indication, and dosage form. On the basis of the infection type, the market is segmented as superficial fungal infection and systemic antifungal infection. Based on the drug type, the Antifungal Drugs market is segmented into echinocandins, azoles, polyenes, allylamines, and others. On the basis of the therapeutic indication, the Antifungal Drugs market is segmented into aspergillosis, dermatophytosis, candidiasis, and others. By dosage form, the market is segmented into drugs, ointment, powder, and others.  The market for Antifungal Drugs is expected to grow significantly due to factors such as rising incidences for the fungal infection of the skin, nails and hair, increasing incidences of cancers, HIV, and hospital-acquired infections and favorable government initiatives to combat the antifungal diseases are likely to drive the growth of the Antifungal Drugs market. However, lack of awareness regarding the fungal infections may restrict the growth of Antifungal Drugs market. 3

4. Email: sales@theinsightpartners.com Key Segment Market Segment By Type:-  By Infection Type (Superficial Fungal Infection, Systemic Fungal Infection)  Drug Type (Echinocandins, Azoles, Polyenes, Allylamines, Others)  Therapeutic Indication (Aspergillosis, Dermatophytosis, Candidiasis, Others)  Dosage form (Drugs, Ointment, Powder, Others) Download Sample Here 4

5. Email: sales@theinsightpartners.com $50,000 Antifungal Drugs Market Value $40,000 $30,000 CAGR of 3.2% $20,000 (2019 - 2027) $10,000 $0 20XX 20XX 20XX 20XX 20XX Download Sample 5

6. Email: sales@theinsightpartners.com Company Profiles  Pfizer Inc.  Sanofi S.A.  Gilead Sciences, Inc.  Merck And Co., Inc.  Scynexis Inc.  Novartis International AG  Abbott Laboratories  Bayer AG  Glenmark Pharmaceutical  Glaxosmithkline Plc. Download Sample Here 6

7. Email: sales@theinsightpartners.com By Geography  North America (the US, Canada, and Mexico)  Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe)  Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific)  Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa)  South & Central America (Brazil, Argentina, and the Rest of South & Central America). 7

8. THANK YOU! Phone : +1-646-491-9876 E-Mail : sales@theinsightpartners.com